Login to Your Account

About BioWorld

BioWorld delivers actionable intelligence on the most innovative drug development science that drives the business, which funds the means to heal disease. With writers and editors stationed around the globe, BioWorld reports the breaking news — and provides key perspective — on hundreds of medicines in development, the companies behind those therapeutic candidates, the business development transactions that evolve the market, and the regulatory hurdles that both challenge and guard the process.

Daily news coverage includes:

  • Therapeutic product development from early to late stage
  • Strategic alliances, mergers and acquisitions
  • Corporate financings, both public and private
  • Biopharma company advancements and setbacks
  • Scientific milestones
  • Global regulatory updates
  • Profiles of new and drug development innovators
  • Big pharma's growing involvement in biotech

In addition to original daily news reporting, BioWorld offers an extensive searchable database at www.BioWorld.com with two decades' worth of biopharmaceutical news archives. This site is not only a great source for insightful, up-to-the-minute news coverage, but a veritable library of information, analysis and data on the developments of the industry as well. With a quick search, BioWorld subscribers have instant access to a wealth of biopharmaceutical market intelligence from around the globe. Also included is BioWorld Snapshots — an exclusive online product updated daily with market data, such as collaborations, mergers, acquisitions, financings, market cap rankings and more.

BioWorld Products

All of the BioWorld resources are available for easy online searching, including:

Join the discussion on BioWorld's blog at BioWorld.blogs.BioWorld.com and follow us on Twitter, LinkedIn and Facebook.

BioWorld, the recognized leader in biotech news for more than 20 years.